ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryLuganoCuoralia Therapeutics Sagl
CT
Verified· 1 sourceTrust ScoreNo score yet

Cuoralia Therapeutics Sagl

Summary

About the company

The promotion, development, coordination and provision of services related to scientific activities, basic research, clinical research, experimentation, development and production, on its own behalf or on behalf of third parties, of diagnostics involving genetic engineering for pharmaceutical use, of intermediate or finished products intended for the pharmaceutical, biotechnology, chemical and cosmetic industries; the research, development and marketing of new connection devices for ultrafiltration and/or dialysis techniques; the research, development and marketing of new hemofiltration devices for the treatment of cardiac dysfunctions; the research, development and marketing of hypertonic solutions for the ultrafiltration treatment of cardiac dysfunctions; the research, development and marketing of hypertonic solutions for the treatment of pathologies characterized by hyperhydration; the exploitation of industrial property rights, registered and unregistered, acquired by the company in the above-mentioned sectors, both originally and derivatively and/or by virtue of licensing agreements, both active and passive; the national and international registration, extension, acquisition and transfer to third parties of patents and/or industrial property rights related to the activity mentioned above; the production, processing, packaging and distribution of special medicines for human and veterinary use, galenic, chemical, biological and diagnostic products, medical-surgical devices and sanitary articles, medicinal plants and their derivatives, bioelectronic and analytical equipment, scientific and technical instrumentation; the production, processing, packaging and distribution of dietary and food products, cosmetic products, aromatic plants, perfumes and their derivatives; the editing, printing and distribution of scientific publications, editorial activity, including audiovisual media, related to the company's activity, excluding daily newspapers and the sale of training and information services. The company may also provide scientific and technical consulting services to group companies or third parties, facilitate the exchange of information and materials between research units, also in the context of collaboration with other third-party entities, research organizations, and public and private research institutes, centers and laboratories operating in the sector. The company, both in Switzerland and abroad, may, provided that it is deemed instrumental to the above-mentioned purpose or necessary for its achievement: take over the management, operation, liquidation of other companies or enterprises with the same social purpose; carry out all industrial, commercial, financial, movable and immovable operations; take direct or indirect interests or participations in other companies or enterprises with a similar, related or connected purpose, as well as provide guarantees, sureties and guarantees, both real and personal, also in favor of third parties, without limitation, provided that it is in the social interest. The particular enumeration does not limit the company's activity in any way, which must be referred to the broader social purpose. The company also has the possibility of carrying out all other real estate, movable, commercial and financial activities deemed useful for achieving the social purpose, including the granting of real and personal guarantees in favor of third parties.

Commercial register, canton of TI·As of January 12, 2026View on Zefix
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Trust & reputation

ranQ Trust Score of Cuoralia Therapeutics Sagl

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Website authority, Media authority

Data basis 50% · As of October 2026

Cuoralia Therapeutics Sagl has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Cuoralia Therapeutics Sagl scores 80.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.95.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Cuoralia Therapeutics Sagl scores 58.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).58.322%
Cuoralia Therapeutics Sagl has no value in the Visibility area of the ranQ Trust Score because no data is available. The area carries 8% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Website authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 50%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Website authority, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Cuoralia Therapeutics Sagl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Cuoralia Therapeutics Sagl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Cuoralia Therapeutics Sagl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Cuoralia Therapeutics Sagl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Corso Elvezia 37
6900 Lugano

At a glance

Legal form
Limited Liability Company
UID
CHE-413.458.988
Founded
2013 · 13 years
Last commercial register change
January 12, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    CS
    Contrad Swiss SA
    Lugano
    OG
    OmniCap GmbH
    Lugano
    NN
    NAIE Natural Alternatives International Europe SA
    Manno
    IH
    IBSA Holding SA
    Montagnola
    HH
    HAS Healthcare Advanced Synthesis SA
    Biasca
    DS
    DEVELOPHARMA SA
    Manno
    PT
    PHARMA TICINO SA
    Manno
    HH
    Helsinn Healthcare SA
    Pazzallo